- Home
- JZXN vs CCEL Comparison
JZXN vs CCEL Comparison
Compare JZXN & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- CCEL
- Stock Information
- Founded
- JZXN 2017
- CCEL 1989
- Country
- JZXN China
- CCEL United States
- Employees
- JZXN 33
- CCEL N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- CCEL Managed Health Care
- Sector
- JZXN Consumer Discretionary
- CCEL Health Care
- Exchange
- JZXN Nasdaq
- CCEL Nasdaq
- Market Cap
- JZXN 45.5M
- CCEL 50.0M
- IPO Year
- JZXN 2021
- CCEL 1997
- Fundamental
- Price
- JZXN $4.37
- CCEL $7.71
- Analyst Decision
- JZXN
- CCEL
- Analyst Count
- JZXN 0
- CCEL 0
- Target Price
- JZXN N/A
- CCEL N/A
- AVG Volume (30 Days)
- JZXN 170.6K
- CCEL 15.0K
- Earning Date
- JZXN 09-09-2024
- CCEL 04-14-2025
- Dividend Yield
- JZXN N/A
- CCEL 3.11%
- EPS Growth
- JZXN N/A
- CCEL N/A
- EPS
- JZXN N/A
- CCEL N/A
- Revenue
- JZXN $7,597,423.00
- CCEL $31,838,476.00
- Revenue This Year
- JZXN N/A
- CCEL $3.97
- Revenue Next Year
- JZXN N/A
- CCEL $0.91
- P/E Ratio
- JZXN N/A
- CCEL N/A
- Revenue Growth
- JZXN 81.94
- CCEL 1.95
- 52 Week Low
- JZXN $1.00
- CCEL $4.47
- 52 Week High
- JZXN $67.60
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- JZXN 70.40
- CCEL 48.98
- Support Level
- JZXN $3.53
- CCEL $7.26
- Resistance Level
- JZXN $6.46
- CCEL $8.20
- Average True Range (ATR)
- JZXN 0.74
- CCEL 0.54
- MACD
- JZXN 0.17
- CCEL -0.02
- Stochastic Oscillator
- JZXN 55.05
- CCEL 34.15
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its business segments are sales of NEVs and Franchisees services. The company generates a majority of its revenue from the NEVs segment. Geographically, the firm operates in China.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.